Literature DB >> 17073556

Neutrophil infiltration and chemokines.

Yoshiro Kobayashi1.   

Abstract

Neutrophil infiltration is mainly mediated by ELR+ CXC chemokines and is regulated through interactions between various stimulants and cells, which are perhaps more complex than previously thought. In this review, I describe the current view of the roles of neutrophil-selective chemokines such as IL-8, MIP-2, and KC by choosing several in vivo models. I also illustrate how these three chemokines are induced and how they are involved in neutrophil infiltration. Finally, I introduce synthetic compounds with high efficacy in the prevention of ischemia reperfusion injury.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17073556     DOI: 10.1615/critrevimmunol.v26.i4.20

Source DB:  PubMed          Journal:  Crit Rev Immunol        ISSN: 1040-8401            Impact factor:   2.214


  81 in total

1.  CXCL5 regulates chemokine scavenging and pulmonary host defense to bacterial infection.

Authors:  Junjie Mei; Yuhong Liu; Ning Dai; Michael Favara; Teshell Greene; Samithamby Jeyaseelan; Mortimer Poncz; Janet S Lee; G Scott Worthen
Journal:  Immunity       Date:  2010-07-23       Impact factor: 31.745

2.  Activation of Toll-like receptor 5 on breast cancer cells by flagellin suppresses cell proliferation and tumor growth.

Authors:  Zhenyu Cai; Amir Sanchez; Zhongcheng Shi; Tingting Zhang; Mingyao Liu; Dekai Zhang
Journal:  Cancer Res       Date:  2011-03-22       Impact factor: 12.701

3.  Porphyromonas gulae Has Virulence and Immunological Characteristics Similar to Those of the Human Periodontal Pathogen Porphyromonas gingivalis.

Authors:  Jason C Lenzo; Neil M O'Brien-Simpson; Rebecca K Orth; Helen L Mitchell; Stuart G Dashper; Eric C Reynolds
Journal:  Infect Immun       Date:  2016-08-19       Impact factor: 3.441

4.  A little cooperation helps murine cytomegalovirus (MCMV) go a long way: MCMV co-infection rescues a chemokine salivary gland defect.

Authors:  Pranay Dogra; Mindy Miller-Kittrell; Elisabeth Pitt; Joseph W Jackson; Tom Masi; Courtney Copeland; Shuen Wu; William E Miller; Tim Sparer
Journal:  J Gen Virol       Date:  2016-09-13       Impact factor: 3.891

5.  Assessment of immune activation in mice before and after eradication of mite infestation.

Authors:  Nancy A Johnston; Rita A Trammell; Susan Ball-Kell; Steven Verhulst; Linda A Toth
Journal:  J Am Assoc Lab Anim Sci       Date:  2009-07       Impact factor: 1.232

6.  Effects of Estrogen on Bacterial Clearance and Neutrophil Response After Combined Burn Injury and Wound Infection.

Authors:  Timothy P Plackett; Cory R Deburghraeve; Jessica L Palmer; Richard L Gamelli; Elizabeth J Kovacs
Journal:  J Burn Care Res       Date:  2016 Sep-Oct       Impact factor: 1.845

7.  Neutrophil survival and c-kit(+)-progenitor proliferation in Staphylococcus aureus-infected skin wounds promote resolution.

Authors:  Min-Ho Kim; Jennifer L Granick; Cindy Kwok; Naomi J Walker; Dori L Borjesson; Fitz-Roy E Curry; Lloyd S Miller; Scott I Simon
Journal:  Blood       Date:  2011-01-28       Impact factor: 22.113

8.  Suppression of lipopolysaccharide- and tumour necrosis factor-alpha-induced interleukin (IL)-8 expression by glucocorticoids involves changes in IL-8 promoter acetylation.

Authors:  L G Tsaprouni; K Ito; I M Adcock; N Punchard
Journal:  Clin Exp Immunol       Date:  2007-08-17       Impact factor: 4.330

9.  Hypoxia potentiates allergen induction of HIF-1α, chemokines, airway inflammation, TGF-β1, and airway remodeling in a mouse model.

Authors:  Kwang Je Baek; Jae Youn Cho; Peter Rosenthal; Laura E Crotty Alexander; Victor Nizet; David H Broide
Journal:  Clin Immunol       Date:  2013-02-21       Impact factor: 3.969

10.  Divergent systemic and local inflammatory response to hind limb demand ischemia in wild-type and ApoE-/- mice.

Authors:  Robert S Crawford; Hassan Albadawi; Alessandro Robaldo; Michael A Peck; Christopher J Abularrage; Hyung-Jin Yoo; Glenn M Lamuraglia; Michael T Watkins
Journal:  J Surg Res       Date:  2013-03-15       Impact factor: 2.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.